Liquid diet study for new Crohn's in kids and teens
Part of Digestive system clinical trials.
This study tests a special liquid diet (smoothie) to treat newly diagnosed Crohn's disease in children and young adults. It aims to understand how the diet works and if it can help reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age must be between 8 and 21 years old.
- Diagnosed with Crohn's disease within the last 2 years.
- Currently has active inflammation or symptoms (like belly pain, diarrhea) and high lab markers.
- Has not been treated with exclusive enteral nutrition (liquid diet) or biologics before.
- No prior Crohn's-related surgery or active perianal disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special liquid nutrition drink (Modulen) to help children with Crohn's disease reach and stay in remission. It is for children with mild to moderate disease who are starting this type of therapy.
This study looks at how a specific amino-acid (threonine) diet affects adults with Crohn’s disease and signs of intestinal inflammation. It may help researchers understand what dietary protein needs could support more stable disease.
This study looks at how cells in the intestine process waste (a process called autophagy) in children with Crohn's disease. It aims to better understand the disease and may lead to better treatments in the future.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This trial studies a combination of immune-suppressing treatments for children with Crohn’s disease that is not well controlled. It may help reduce inflammation and improve symptoms if you meet the study’s disease-activity and safety requirements.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.